AI assistant
Melexis N.V. — Share Issue/Capital Change 2021
Mar 3, 2021
3975_iss_2021-03-03_d2e7524f-6b7b-4f03-bf71-91f798a625c6.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer
NOT FOR DISTRIBUTION, RELEASE, OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN, SOUTH-AFRICA OR SWITZERLAND OR ANY PERSON BASED IN THESE COUNTRIES
Xtrion and Melexis have successfully completed private placement of Melexis shares
MAR 3, 2021
Press Release – Inside Information – Regulated Information
Intermediate declaration by the Board of Directors
Ieper, Belgium – March 3rd, 2021, 8.00 hrs CET
Melexis NV ("Melexis"), a global microelectronics engineering company, Melexis Technologies NV ("Melexis Technologies") and Xtrion NV ("Xtrion"), a holding company and majority shareholder of Melexis (jointly referred to as the "sellers"), have successfully completed the private placement of 1,790,539 existing shares - c. 4.43 % of the capital - of Melexis (the "shares").
Following the sale, Xtrion will remain Melexis' majority shareholder (50% + 1 share). It is Xtrion's intention and vision to retain a controlling stake in Melexis' share capital for the foreseeable future.
The shares have been placed at a price of 88.50 EUR per share.
Settlement will take place on March 5th, 2021.
Trading of the Melexis share on Euronext Brussels has been suspended since March 2nd, 2021, 13.30 hrs CET and will resume at market opening today.
Belfius SA/NV, in cooperation with Kepler Cheuvreux S.A., and BNP Paribas Fortis SA/NV acted as Joint Global Coordinators and Joint Bookrunners in connection with the placement.
Important Legal Information
This announcement is not for publication or distribution, directly or indirectly, in or into the United States of America. This announcement is not an offer of securities for sale into the United States. The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933, as amended, and may not be offered or sold in the United States, except pursuant to an applicable exemption from registration. No public offering of securities is being made in the United States.